CervoMed Inc.
CRVO
$2.73
-$0.20-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -99.60% | -83.37% | -46.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -99.60% | -83.37% | -46.56% |
| Cost of Revenue | 13.20% | 6.15% | -17.73% | 17.86% | -96.79% |
| Gross Profit | -108.38% | -75.85% | -18.21% | -79.51% | 438.56% |
| SG&A Expenses | -27.83% | 24.87% | 8.37% | 5.22% | 30.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.25% | 12.33% | -11.30% | 14.05% | 33.26% |
| Operating Income | -0.94% | -52.94% | -15.06% | -49.07% | -120.90% |
| Income Before Tax | -5.01% | -62.73% | -20.60% | -62.55% | -170.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.01% | -62.73% | -20.60% | -62.55% | -170.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.01% | -62.73% | -20.60% | -62.55% | -170.12% |
| EBIT | -0.94% | -52.94% | -15.06% | -49.07% | -120.90% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 8.25% | -52.95% | -13.47% | -52.89% | -162.66% |
| Normalized Basic EPS | 8.26% | -52.94% | -13.46% | -52.87% | -162.62% |
| EPS Diluted | 8.25% | -52.95% | -13.47% | -52.89% | -162.66% |
| Normalized Diluted EPS | 8.26% | -52.94% | -13.46% | -52.87% | -162.62% |
| Average Basic Shares Outstanding | 14.46% | 6.38% | 6.29% | 6.32% | 2.85% |
| Average Diluted Shares Outstanding | 14.46% | 6.38% | 6.29% | 6.32% | 2.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |